Humira and biosimilars — CareFirst (Caremark)
uveitis (non-infectious intermediate, posterior, and panuveitis)
Initial criteria
- Age ≥ 2 years
- Member previously received biologic indicated for non-infectious uveitis OR inadequate response to corticosteroids or immunosuppressive therapy (azathioprine, cyclosporine, methotrexate, mycophenolate mofetil) OR intolerance/contraindication to such therapies
Approval duration
12 months